Cardiac arrest & resuscitation
Mortality and healthcare resource utilisation after cardiac arrest in the United States – A 10-year nationwide analysis prior to the COVID-19 pandemic
Authors' conclusion
Over the last ten years prior to the COVID-19 pandemic, CA-related survival has incrementally improved with shorter hospitalisations and increased medical expenses, while strong disparities existed among different age groups and ethnicities.
Study context
- Population
- Hospitalised adults with cardiac arrest (without DNR orders), United States (US), 2010–201957.5% male
- Participants
- 248,754 adults
- Outcome
- In-hospital mortality and healthcare resource utilisation
Methodological detailsnationwide, US National Inpatient Sample, adjusted for 47 confounders
- Nationwide
- US National Inpatient Sample
- Adjusted for 47 confounders
Main finding
As reported in the abstract
In-hospital mortality
Overall in-hospital mortality
51.2%
In-hospital mortality 2010 vs 2019
58.3% to 46.4%
P < 0.001
Observational data: associations, not effects.
Further findings
Healthcare resource utilisation · 2010 to 2019
- Average hospital LOS decreased
- 11%
- Hospital expenses increased
- 13%
- ECMO use
- 2.6% to 8.7%
- Impella use
- 1.8% to 14.2%
- Each P < 0.001 (LOS and expenses)
Young adults with cardiac arrest (CA) and opioid-induced CA
- Number almost doubled within study period
Original publication
Mortality and healthcare resource utilisation after cardiac arrest in the United States – A 10-year nationwide analysis prior to the COVID-19 pandemic. Resuscitation. Published 25 August 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →